Total medical devices industry deals worth $8.1bn were announced globally for May 2021, with the $1.36bn acquisition of Vectura Group being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 6.8% over the previous month of $7.56bn and a drop of 6.3% when compared with the last 12-month average of $8.61bn.

In terms of number of deals, the sector saw a drop of 10.30% with 148 deals in May 2021 when compared to the last 12-month average of 165 deals.

In value terms, North America led the activity with deals worth $4.61bn in May 2021.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medical Devices industry deals in May 2021: Top deals

The top five deals accounted for 45.4% of the overall value during May 2021.

The combined value of the top five deals stood at $3.67bn, against the overall value of $8.1bn recorded for the month.

The top five medical devices industry deals of May 2021 tracked by GlobalData were:

1) Murano Bidco’s $1.36bn acquisition of Vectura Group

2) The $830m private equity deal with Caris Life Sciences by L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment

3) Allergan Aesthetics’ $550m acquisition of Soliton

4) The $540m venture financing deal of Noom by Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)

5) NeoGenomics’ acquisition deal with Inivata for $390m.